Dam, T, Golbe, LI, Hoglinger, GU, Grundman, M, Yang, LL, Tidemann-Miller, B, Kupferman, J, Harper, K, Kamisoglu, K, Wald, MJ, Graham, DL, Gedney, L, O'Gorman, J, Haeberlein, SB, Aiba, I, Antonini, A, Apetauerova, D, Azulay, JP, Martinez, EB, Bang, J, Barone, P, Barrett, M, Bega, D, Berg, D, Corrales, KB, Bordelon, Y, Boxer, AL, Brandt, M, Brueggemann, N, Castelnovo, G, Ceravolo, R, Chuang, RD, Chung, SJ, Church, A, Corvol, JC, Cudia, P, Dale, M, Defebvre, L, Drapier, S, Driver-Dunckley, ED, Ebersbach, G, Eggert, KM, Ellenbogen, A, Eusebio, A, Evans, AH, Fedorova, N, Finger, E, Foubert-Samier, A, Ghosh, B, Golbe, L, Perez, FG, Grossman, M, Hall, D, Hamada, K, Hasegawa, K, Hoeglinger, G, Honig, L, Houghton, D, Huang, XM, Isaacson, S, Koh, S, Bojarski, JK, Lang, ANE, Leigh, PN, Litvan, I, Lozano, JJL, Moreno, JLLS, Ludolph, AC, Piudo, MRL, Torres, IM, McFarland, N, Meissner, W, Mestre, T, Rivera, PM, Molho, E, Mollenhauer, B, Morris, HR, Murata, M, Obi, T, Magne, FO, O'Suilleabhain, P, Pahwa, R, Pantelyat, A, Pavese, N, Pokhabov, D, Prudlo, J, Rodriguez-Porcel, F, Rowe, J, Savitt, J, Schnitzler, A, Schulz, JB, Seppi, K, Shah, BI, Shill, H, Shprecher, D, Stamelou, M, Steiger, M, Takahashi, Y, Takigawa, H, Tartaglia, C, Toenges, L, Truong, D, Tse, W, Tuite, P, Volc, D, Wills, AMA, Woitalla, D, Xie, T, Yuasa, T, Zauber, SE, Zesiewicz, T. Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (August, 10.1038/s41591-021-01455-x, 2021). NATURE MEDICINE. 2023; 29(11)DOI:10.1038/s41591-022-02076-8. PMID:36253611. IF:58.700(Q1/1D).

Mezquida G., Amoretti S., Bioque M., García-Rizo C., Sánchez-Torres A.M., Pina-Camacho L., Lopez-Pena P., Mané A., Rodriguez-Jimenez R., Corripio I., Sarró S., Ibañez A., Usall J., García-Portilla M.P., Vieta E., Mas S., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Bernardo M.. Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2023; 16(3)DOI:10.1016/j.rpsm.2023.01.004. PMID:37716849. IF:9.200(Q/D).

Revilla, G, Al Qtaish, N, Caruana, P, Sainz-Ramos, M, Lopez-Mendez, T, Rodriguez, F, Paez-Espinosa, V, Li, CD, Vallverdú, NF, Edwards, M, Moral, A, Pérez, JI, Escolà-Gil, JC, Pedraz, JL, Gallego, I, Corcoy, R, Céspedes, MV, Puras, G, Mato, E. Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior. Biomolecules. 2023; 13(11)DOI:10.3390/biom13111647. PMID:38002329. IF:4.800(Q1/3D).

Gimeno, M, Garcia, JA, Afan, I, Aymi, R, Montalvo, T, Navarro, J. Age-related differences in foraging behaviour at sea and interactions with fishing vessels in an opportunistic urban gull. ICES JOURNAL OF MARINE SCIENCE. 2023; 80(9)DOI:10.1093/icesjms/fsac120. PMID:. IF:3.100(Q1/1D).